direct Xa inhibition
Showing 1 - 25 of 9,876
Coagulation Disorder Trial (PROTHROMPLEX TOTAL, 4F-PCC)
Not yet recruiting
- Coagulation Disorder
- PROTHROMPLEX TOTAL
- 4F-PCC
- (no location specified)
Jul 14, 2022
Traumatic Brain Injury Trial (transcranial direct current stimulation, transcranial pulsed current stimulation, Sham-no
Withdrawn
- Traumatic Brain Injury
- transcranial direct current stimulation
- +2 more
- (no location specified)
Dec 13, 2021
Low Back Pain Trial in Aalborg (High-Definition Transcranial Direct Current Stimulation)
Completed
- Low Back Pain
- High-Definition Transcranial Direct Current Stimulation
-
Aalborg, DenmarkCNAP, SMI, Aalborg University
Dec 10, 2020
Anticoagulation in Patients on ECMO for Severe Lung Failure
Completed
- ARDS
- COVID-19
- Argatroban Injection
- Heparin
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Sep 18, 2023
SCAD, AMI Trial in Sao Paulo (ASA, Clopidogrel, Edoxaban)
Recruiting
- SCAD
- AMI
- ASA
- +2 more
-
Sao Paulo, BrazilInstituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
Nov 4, 2021
Rivaroxaban - Percutaneous Coronary Intervention
Completed
- Coronary Artery Disease
- Atrial Fibrillation
- In vitro heparin
-
Bursa, TurkeyBursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Sep 13, 2022
Sickle Cell Anemia, Sickle Cell-Beta0-Thalassemia Trial in Chapel Hill (rivaroxaban, )
Completed
- Sickle Cell Anemia
- Sickle Cell-Beta0-Thalassemia
- rivaroxaban
- placebo
-
Chapel Hill, North CarolinaUniversity of North Carolina - Chapel Hill
Apr 9, 2020
Specific PoC Testing of Coagulation in Patients Treated With
Recruiting
- Anticoagulation With NOAC
- anti-Xa activity point-of-care testing (aXa-POCT)
- ecarin clotting time point-of-care testing (ECT-POCT)
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Dec 14, 2020
Hypothermia and Acidosis on Coagulation During Treatment With
Recruiting
- Trauma
- +3 more
- Rivaroxaban 15 MG
-
Lund, Skåne, SwedenSkåne University Hospital
Dec 30, 2022
Urin-based Point-of-Care Testing for Direct Oral Anticoagulants
Recruiting
- Stroke
- Urin-based test by the DOASENSE Dipstick Device
-
Gießen, Hesse, GermanyDepartment of Neurology, University Hospital Giessen
Sep 13, 2023
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19
Completed
- Critical Illness
- +2 more
- blood sampling
-
Arnhem, NetherlandsMonique de Maat
Jun 28, 2023
Antiphospholipid Syndrome, Anticoagulant Drugs Trial in Clermont-Ferrand (Lupus anticoagulant testing)
Recruiting
- Antiphospholipid Syndrome
- Anticoagulant Drugs
- Lupus anticoagulant testing
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 13, 2022
MDS Trial in Beijing (Lenalidomide, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Brain Connectivity Between Networks Implied in Inhibition and
Not yet recruiting
- Alcohol Use Disorder
- Go-Nogo-task during functional magnetic resonance imaging
- Resting-state functional magnetic resonance imaging
-
Bern, SwitzerlandUniversity Hospital for Psychiatry and Psychotherapy Bern
Apr 24, 2023
Spinal Cord Injuries Trial in Istanbul (Tendon tap, Tibial nerve stimulation)
Completed
- Spinal Cord Injuries
- Tendon tap
- Tibial nerve stimulation
-
Istanbul, Turkeyİstanbul Physical Therapy Training and Research Hospital
Aug 11, 2023
Chronic Renal Failure Trial in Valinhos (Heparin sodic, heparin liquemine)
Suspended
- Chronic Renal Failure
- Heparin sodic
- heparin liquemine
-
Valinhos, Sao Paulo, BrazilLal Clinica Pesquisa E Desenvolvimento Ltda
Nov 1, 2022
Stroke, Paresis, Upper Extremity Paralysis Trial in Rome (Real dual tDCS + Robotic Arm Therapy, SHAM tDCS + Robotic Arm Therapy)
Completed
- Stroke
- +2 more
- Real dual tDCS + Robotic Arm Therapy
- SHAM tDCS + Robotic Arm Therapy
-
Rome, Italy
- +1 more
Jul 7, 2022
Venous Thromboembolism Trial in Russian Federation (Dimolegin 40 mg, Dimolegin 60 mg, Fragmin)
Active, not recruiting
- Venous Thromboembolism
- Dimolegin 40 mg
- +2 more
-
Bryansk, Russian Federation
- +14 more
Apr 25, 2022
Interference Between Oral Anticoagulants and Heparin During
Recruiting
- Atrial Fibrillation
- Atrial Tachycardia
-
Paris, FranceHopital Bichat-Claude Bernard
Mar 27, 2023
Aortic Valve Disease Trial in Paris (Apixaban 5 MG Oral Tablet, warfarin with an objective of INR target of 2.5 (range:
Not yet recruiting
- Aortic Valve Disease
- Apixaban 5 MG Oral Tablet
- warfarin with an objective of INR target of 2.5 (range: 2.0-3.0)
-
Paris, FranceService de Cardiologie Hôpital Lariboisière
Jan 24, 2023
Health Care Interventions and Outcomes of Major Bleedings in
Not yet recruiting
- Major Bleeding
- None (Observational study)
- (no location specified)
Nov 17, 2023
Binge Drinking Trial in Braga (Active tDCS, Sham tDCS, Active CT)
Completed
- Binge Drinking
- Active tDCS
- +3 more
-
Braga, PortugalSchool of Psychology
Nov 2, 2022
Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])
Not yet recruiting
- Liver Cirrhosis
- Apixaban 5 MG [Eliquis]
- Edoxaban 60 MG [Lixiana]
- (no location specified)
May 19, 2023